Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats

Phytotherapy Research

Volumn 16, Issue 6, 2002, Pages 514-518

  Vidya, Lakshminarasimhan ^a   Lenin, Mahimainathan ^a   Varalakshmi, Palaninathan ^a  

^a Dr ALM Postgraduate Institute of Basic Medical Sciences   (India)

Author keywords

Enzymuria; Hyperoxaluria; Lupeol; Lupeol linoleate; Triterpenes

Indexed keywords

ACETYLGLUCOSAMINIDASE; ALKALINE PHOSPHATASE; BETA GLUCURONIDASE; CALCIUM OXALATE; GAMMA GLUTAMYLTRANSFERASE; GLYCOLIC ACID; GLYCOSAMINOGLYCAN; LACTATE DEHYDROGENASE; LUPEOL; LUPEOL LINOLEATE; MAGNESIUM; PYRIDOXINE; TRITERPENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; ENZYMURIA; HYPEROXALURIA; KIDNEY TUBULE DISORDER; NONHUMAN; PYRIDOXINE DEFICIENCY; RAT; UROLITHIASIS;

ACETYLGLUCOSAMINIDASE; ALKALINE PHOSPHATASE; ANIMALS; CALCIUM; CALCIUM OXALATE; GAMMA-GLUTAMYLTRANSFERASE; GLUCURONIDASE; HYPEROXALURIA; L-LACTATE DEHYDROGENASE; MALE; OXALATES; PYRIDOXINE; RATS; RATS, WISTAR; RISK FACTORS; TRITERPENES; URIC ACID; URINARY CALCULI;

EID: 0036741528     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.940     Document Type: Article

References (27)

1. th Soc Conf, A10
2. Anand R, Patnaik GK, Kulshreshta DK, Dhawan BN. 1992. Antiurolithiatic and diuretic activity of lupeol, the active constituent isolated from Crateava nurvala (Buch. Ham). Indian J Pharmacol 24: 48-49
3. Anand R, Patnaik GK, Kulshreshta DK, Dhawan BN. 1994. Antiurolithiatic activity of lupeol, the active constituent isolated from Crataeva nurvala. Phytother Res 8: 417-421
4. Balaji KC, Menon M. 1997. Mechanism of stone formation. Urol Clin North Am 24: 1-11
5. Baskar R, Malini MM, Varalakshmi P, Balakrishna K, Rao KB. 1996. Effect of lupeol isolated from Crataeva nurvala stem bark against free radical induced toxicity in experimental rats. Fitoterapia LXVII: 121-125
6. Chow FHC, Hamar DW, Udhall RH. 1974. Prevention of oxalate and phosphate lithiasis by alanine. Invest Urol 12: 50-53
7. El Sharabasy. 1992. Observations in calcium oxalate stone formers. Br J Urol 70: 474-477
8. Geetha T, Varalakshmi P. 1998. Anti-inflammatory activity of lupeol and lupeol linoleate in adjuvant-induced arthritis. Fitoterapia 1: 13-20
9. Grases F, Costa-Bauza A, March JG, Masarova L. 1991. Glycosaminoglycans, uric acid and calcium oxalate urolithiasis. Urol Res 19: 375-380
10. Hwang TIS, Preminger GM, Poindexter J, Pak CYC. 1988. Urinary glycosaminoglycans in normal subjects and patients with stones. J Urol 139: 995-997
11. Jayanthi S, Varalakshmi P. 1993. Changes in urinary excretion pattern in experimental calcium oxalate lithiasis and the effect of DL α lipoic acid. Med Sci Res 21: 37-39
12. Khan SR, Shevock PN, Hackett RL. 1989. Urinary enzymes and calcium oxalate urolithiasis. J Urol 142: 846-849
13. Khan SR, Shevock PN, Hackett RL. 1993. Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis. J Urol 149: 412
14. King J. 1965. The hydrolases - acid and alkaline phosphatase. In Practical Clinical Enzymology, Van D (ed.). Nostrand Co. Ltd.; London
15. Klahr S. 1991. Chronic renal failure: management. Lancet 338: 423-427
16. Lowry OH, Rosebrough NJ, Farr Al, Randall RJ. 1951. Protein measurement with folin-phenol reagent. J Biol Chem 193:265-275
17. Malini MM, Baskar R, Varalakshmi P. 1995. Effect of lupeol, a pentacyclic triterpene, on urinary enzymes in hyperoxaluric rats. Jpn J Med Sci Biol 48:211-220
18. Marhun D. 1976. Rapid colorimetric assay of β-galactosidase and N-acetyl β-Dglucosaminidase in human urine. Clin Chem Acta 73: 453
19. Natelson S, Scott ML, Beffa C. 1951. A rapid method for the estimation of urea in biological fluids by means of the reaction with diacetyl monoxime and urea. Am J Clin Path 21: 275-281
20. Okai GK, Carrol AR. 1992. In Recent Advances in Toxicology Research, Kone PG, Tan CK, (eds). VTRG Publishers; Singapore
21. Owen JA, Iggo TB, Scandrett FJ, Stemart IP. 1954. Determination of creatinine in plasma or serum and in urine, a critical examination. Biochem J 58: 426-437
22. Resnick MI, Boyce WH. 1979. Low molecular weight protein and renal lithiasis. Invest Urol 16: 270-273
23. Rushton HG, Spector M. 1982. Effects of magnesium deficiency on intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats. J Urol 127: 598-604
24. Senthil D, Malini MM, Varalakshmi P. 1998. A novel inhibitor of urinary risk factors and enzymes in experimental urolithiatic rats. Renal Failure 20: 573-580
25. Subha K, Varalakshmi P. 1993. Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate. Biochem Mol Biol Int 29: 271-280
26. Van Aswegen CH, Nertz AWH, Bekker PJ, du Plessis DJ. 1988. Renal calculiurate as a urokinase inhibitor. Urol Res 16: 143-148
27. Wangoo D, Siddhu H, Vaidyanath S et al. 1988. Urinary excretion of lipogenic substances and inhibitory activity towards calcium oxalate monohydrate crystal growth in idiopathic urolithiasis. Urol Res 16: 235